Literature DB >> 23397959

The genotype distribution of the XRCC1, XRCC3, and XPD DNA repair genes and their role for the development of acute myeloblastic leukemia.

Amani Sorour1, Mona Wagdy Ayad, Hala Kassem.   

Abstract

AIM: To investigate if there is an association between the different DNA repair gene polymorphisms and the risk of development of acute myeloid leukemia (AML) in a sample of the Egyptian population and to find out if there is any interaction between these polymorphisms and the NQO1 gene that acts to protect the cells from oxidative damage.
RESULTS: Our study was conducted on 90 patients with de novo AML and 60 healthy subjects with matched age and sex. We studied polymorphisms in three DNA repair genes; XRCC1, XRCC3, and XPD. We also assessed the incidence of the NQO1 gene polymorphism. We genotyped the polymorphisms by polymerase chain reaction- restriction fragment length polymorphism.
CONCLUSION: The distribution of XRCC1Arg 339Gln genotypes showed a significant difference between patients and controls (p=0.025). The presence of at least one XRCC1 399Gln allele indicated an increased risk of AML and the proportion of AML patients homozygous for the Gln/Gln allele was significantly higher than in the control group (p=0.025). However, distributions of the XRCC3 Thr241Met, XPD Lys751Gln, and NQO1Pro 187Ser genotypes were not significantly different between patients and controls. Combined analysis of the studied DNA repair gene polymorphisms did not show an interaction with the detoxification NQO1 Pro187Ser polymorphism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23397959     DOI: 10.1089/gtmb.2012.0278

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  15 in total

1.  Replication analysis confirms the association of several variants with acute myeloid leukemia in Chinese population.

Authors:  Songyu Cao; Guohua Yang; Juan Zhang; Yunfeng Shen; Hongxia Ma; Xifeng Qian; Zhibin Hu
Journal:  J Cancer Res Clin Oncol       Date:  2015-07-16       Impact factor: 4.553

2.  The -786T > C polymorphism in the NOS3 gene is associated with increased cancer risk.

Authors:  Yonggang Zhang; Qingyi Jia; Pei Xue; Yuqi Liu; Tianyuan Xiong; Jiqiao Yang; Chenxi Song; Qing He; Liang Du
Journal:  Tumour Biol       Date:  2014-01-24

3.  Identification of XRCC1 Arg399Gln and XRCC3 Thr241Met Polymorphisms in a Turkish Population and Their Association with the Risk of Chronic Lymphocytic Leukemia.

Authors:  Pelin Mutlu; Mualla Pınar Elçi; Murat Yıldırım; Oral Nevruz; Ahmet Türker Çetin; Ferit Avcu
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-11       Impact factor: 0.900

4.  Association between XRCC3 Thr241Met polymorphism and laryngeal cancer susceptibility in Turkish population.

Authors:  Pelin Mutlu; Murad Mutlu; Serap Yalçın; Atılay Yaylacı; Gözde Ünsoy; Güleser Saylam; İstemihan Akın; Ufuk Gündüz; Hakan Korkmaz
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-16       Impact factor: 2.503

5.  Comprehensive assessment of the association between DNA repair gene XRCC3 Thr241Met polymorphism and leukemia risk.

Authors:  Lingyan Qin; Xu Chen; Ping Li; Zheng Yang; Wuning Mo
Journal:  Tumour Biol       Date:  2013-11-06

6.  Influence of XPC, XPD, XPF, and XPG gene polymorphisms on the risk and the outcome of acute myeloid leukemia in a Romanian population.

Authors:  Claudia Bănescu; Mihaela Iancu; Adrian P Trifa; Minodora Dobreanu; Valeriu G Moldovan; Carmen Duicu; Florin Tripon; Andrei Crauciuc; Cristina Skypnyk; Alina Bogliș; Erzsebeth Lazar
Journal:  Tumour Biol       Date:  2016-01-16

7.  Polymorphism of XRCC1, XRCC3, and XPD genes and risk of chronic myeloid leukemia.

Authors:  Claudia Bănescu; Adrian P Trifa; Smaranda Demian; Erzsebeth Benedek Lazar; Delia Dima; Carmen Duicu; Minodora Dobreanu
Journal:  Biomed Res Int       Date:  2014-05-15       Impact factor: 3.411

8.  The association between XRCC1 Arg399Gln polymorphism and risk of leukemia in different populations: a meta-analysis of case-control studies.

Authors:  Fang Wang; Qian Zhao; Hai-Rong He; Ya-Jing Zhai; Jun Lu; Hai-Bo Hu; Jin-Song Zhou; Yong-Hua Yang; Yuan-Jie Li
Journal:  Onco Targets Ther       Date:  2015-11-06       Impact factor: 4.147

9.  Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies.

Authors:  Haijun Zhang; Hang Liu; Gaofeng Jiang
Journal:  PLoS One       Date:  2013-11-25       Impact factor: 3.240

10.  The PARP inhibitor Olaparib disrupts base excision repair of 5-aza-2'-deoxycytidine lesions.

Authors:  Manuel Luis Orta; Andreas Höglund; José Manuel Calderón-Montaño; Inmaculada Domínguez; Estefanía Burgos-Morón; Torkild Visnes; Nuria Pastor; Cecilia Ström; Miguel López-lázaro; Thomas Helleday
Journal:  Nucleic Acids Res       Date:  2014-07-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.